Dare Current Deferred Revenue from 2010 to 2026
| DARE Stock | USD 1.71 0.00 0.00% |
Current Deferred Revenue | First Reported 2014-12-31 | Previous Quarter 12.3 M | Current Value 1000 K | Quarterly Volatility 5.9 M |
Check Dare Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dare Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.2 K, Interest Expense of 528.6 M or Total Revenue of 10.7 K, as well as many indicators such as Price To Sales Ratio of 2.7 K, Dividend Yield of 0.0 or Days Sales Outstanding of 11.8 K. Dare financial statements analysis is a perfect complement when working with Dare Bioscience Valuation or Volatility modules.
Dare | Current Deferred Revenue | Build AI portfolio with Dare Stock |
Analyzing Dare Bioscience's Current Deferred Revenue over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Current Deferred Revenue has evolved provides context for assessing Dare Bioscience's current valuation and future prospects.
Latest Dare Bioscience's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Dare Bioscience over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Dare Bioscience's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dare Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Dare Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 7,431,290 | |
| Geometric Mean | 4,790,997 | |
| Coefficient Of Variation | 95.71 | |
| Mean Deviation | 6,306,073 | |
| Median | 2,741,000 | |
| Standard Deviation | 7,112,376 | |
| Sample Variance | 50.6T | |
| Range | 18.4M | |
| R-Value | 0.81 | |
| Mean Square Error | 18.4T | |
| R-Squared | 0.66 | |
| Significance | 0.000076 | |
| Slope | 1,143,238 | |
| Total Sum of Squares | 809.4T |
Dare Current Deferred Revenue History
About Dare Bioscience Financial Statements
Dare Bioscience stakeholders use historical fundamental indicators, such as Dare Bioscience's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Dare Bioscience investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dare Bioscience's assets and liabilities are reflected in the revenues and expenses on Dare Bioscience's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dare Bioscience. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 19 M | 20 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dare Bioscience is a strong investment it is important to analyze Dare Bioscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Dare Bioscience's future performance. For an informed investment choice regarding Dare Stock, refer to the following important reports:Check out the analysis of Dare Bioscience Correlation against competitors. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Health Care Equipment & Supplies sector continue expanding? Could Dare diversify its offerings? Factors like these will boost the valuation of Dare Bioscience. Projected growth potential of Dare fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Dare Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.83) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
Understanding Dare Bioscience requires distinguishing between market price and book value, where the latter reflects Dare's accounting equity. The concept of intrinsic value - what Dare Bioscience's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Dare Bioscience's price substantially above or below its fundamental value.
It's important to distinguish between Dare Bioscience's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dare Bioscience should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Dare Bioscience's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.